Octreotide: entering the new era of peptidomimetic therapy.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003457:Cryptosporidiosis / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D015282:Octreotide; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013004:Somatostatin; D015282:Octreotide